5VM
IRON icon

5AM Venture Management’s Disc Medicine IRON Stock Holding History

5AM Venture Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-294,221
Closed -$17M – 27
2023
Q4 		$17M Sell
294,221
-144,221
-33% -$7.38M 4.51% 7
2023
Q3 		$20.6M Sell
438,442
-50,000
-10% -$2.5M 5.93% 3
2023
Q2 		$21.7M Sell
488,442
-100,000
-17% -$3.55M 5.4% 3
2023
Q1 		$12.5M Hold
588,442
– – 3.19% 6
2022
Q4 		$11.7M Buy
588,442
+570,959
+3,266% +$28.4M 3.15% 10
2022
Q3 		$860K Buy
+17,483
New +$825K 0.16% 20

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

5AM Venture Management's IRON Position: Q1 2024 in Review

5AM Venture Management sold out of Disc Medicine (IRON) in Q1 2024, closing a stake of 294,221 shares — an estimated $17M sold.

5AM Venture Management first reported a position in IRON in Q3 2022 and held it in 6 quarters. The position peaked at $21.7M in Q2 2023. 130 funds tracked by Wall St. Rank hold IRON as of Q1 2024.

  • 5AM Venture Management reported no remaining Disc Medicine position as of Q1 2024 after selling out during the quarter.
  • 5AM Venture Management sold 294,221 Disc Medicine shares in Q1 2024, an estimated $17M.
  • 5AM Venture Management first reported a position in Disc Medicine in Q3 2022 and held it in 6 quarters.
  • 5AM Venture Management's Disc Medicine position peaked at $21.7M in Q2 2023.
  • 130 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2024.

Based on 5AM Venture Management's 13F filing for Q1 2024, filed 15 May 2024.